Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00868036 · ClinicalTrials.gov registry record
Evaluating for Contact Allergies in Patients With Chronic Urticaria
A clinical trial of Allergy and Dermatitis, sponsored by Tufts Medical Center.
- Completed
- Registry status
- 23
- Enrollment target
- 1
- Study location
NCT00868036 is a study of Allergy and Dermatitis that has completed, run by Tufts Medical Center. The registered enrollment target is 23 participants, below the 331-participant average among 15 other Allergy trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00868036, a study of Allergy and Dermatitis, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
Hives affects 10-25% of the population worldwide at some time during their lifetime. Hives are itchy transient swellings of the skin lasting 4-36 hours. Chronic urticaria is defined as hives that have been ongoing for six weeks or more. Patch testing is performed to diagnose allergic contact dermatitis, and if contact allergens are found via patch testing, patients can often be cured of their dermatitis. However, patch testing is currently not routinely performed in the evaluation of patients with chronic idiopathic urticaria. Our hypothesis is to see if contact allergens can be identified with patch testing in patients with chronic urticaria, and, if any allergens are identified, to see if avoiding these contact allergens will make the chronic urticaria go away.
Conditions Studied
Interventions
- PROCEDURE Patch Testing
Study Locations (1)
Massachusetts
- Tufts Medical Center, Department of Dermatology - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00868036
The ClinicalTrials.gov registry entry for NCT00868036 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 331-participant average among 15 other Allergy trials with a reported enrollment target (93% lower). The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Allergy appearing as the primary indexed condition, and to 1 intervention - of which Patch Testing is the first listed.
NCT00868036 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00868036 about?
NCT00868036 is a clinical study titled "Evaluating for Contact Allergies in Patients With Chronic Urticaria". Hives affects 10-25% of the population worldwide at some time during their lifetime. Hives are itchy transient swellings of the skin lasting 4-36 hours. Chronic urticaria is defined as hives that have been ongoing for six weeks or more. Patch testing is performed to diagnose allergic contact dermat...
What is the current status of trial NCT00868036?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2008-12. Estimated completion is 2011-01.
What conditions does trial NCT00868036 study?
This clinical trial studies the following conditions: Allergy, Dermatitis, Urticaria, Patch Testing, Contact Sensitization.
What interventions are being tested in trial NCT00868036?
The interventions under investigation include: Patch Testing (PROCEDURE).
Who is sponsoring clinical trial NCT00868036?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00868036 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Allergy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Understanding Allergies and Sensitizations in Healthy and Allergic Individuals
RECRUITING
-
The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron
RECRUITING · Phase 4
-
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
RECRUITING · Phase 3
-
Childhood Allergy and the Neonatal Environment
ACTIVE NOT RECRUITING
-
Urban Environmental Factors and Childhood Asthma
COMPLETED
-
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.